Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Mechanisms of anemia in CKD.

Babitt JL, Lin HY.

J Am Soc Nephrol. 2012 Oct;23(10):1631-4. Epub 2012 Aug 30. Review.

PMID:
22935483
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Hepcidin is a potential regulator of iron status in chronic kidney disease.

Tsuchiya K, Nitta K.

Ther Apher Dial. 2013 Feb;17(1):1-8. doi: 10.1111/1744-9987.12001. Epub 2012 Dec 16. Review.

PMID:
23379486
[PubMed - indexed for MEDLINE]
3.

Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.

Babitt JL, Lin HY.

Am J Kidney Dis. 2010 Apr;55(4):726-41. doi: 10.1053/j.ajkd.2009.12.030. Epub 2010 Feb 26. Review.

PMID:
20189278
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Anemia in chronic kidney disease: new advances.

Patel TV, Singh AK.

Heart Fail Clin. 2010 Jul;6(3):347-57. doi: 10.1016/j.hfc.2010.02.001. Review.

PMID:
20630409
[PubMed - indexed for MEDLINE]
5.

Anemia in children with chronic kidney disease.

Greenbaum LA.

Adv Chronic Kidney Dis. 2005 Oct;12(4):385-96. Review.

PMID:
16198278
[PubMed - indexed for MEDLINE]
6.

The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome.

Silverberg DS.

Heart Fail Rev. 2011 Nov;16(6):609-14. doi: 10.1007/s10741-010-9194-2. Review.

PMID:
20865450
[PubMed - indexed for MEDLINE]
7.

Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease.

Niihata K, Tomosugi N, Uehata T, Shoji T, Mitsumoto K, Shimizu M, Kawabata H, Sakaguchi Y, Suzuki A, Hayashi T, Okada N, Isaka Y, Rakugi H, Tsubakihara Y.

Nephrol Dial Transplant. 2012 Dec;27(12):4378-85; discussion 4384-5. doi: 10.1093/ndt/gfs322. Epub 2012 Jul 24.

PMID:
22833619
[PubMed - indexed for MEDLINE]
8.

[Anemia in chronic kidney disease and its cardiovascular implications].

Cases A, Coll E, Collado S.

Med Clin (Barc). 2009 May;132 Suppl 1:38-42. doi: 10.1016/S0025-7753(09)70961-3. Spanish.

PMID:
19460479
[PubMed - indexed for MEDLINE]
9.

Section two: anemia of chronic kidney disease.

Fiore DC, Fox CL.

FP Essent. 2014 Jan;416:22-5.

PMID:
24432707
[PubMed - indexed for MEDLINE]
10.

Anemia in children with chronic kidney disease.

Atkinson MA, Furth SL.

Nat Rev Nephrol. 2011 Sep 6;7(11):635-41. doi: 10.1038/nrneph.2011.115. Review.

PMID:
21894183
[PubMed - indexed for MEDLINE]
11.

Iron therapy in chronic kidney disease: current controversies.

Kovesdy CP, Kalantar-Zadeh K.

J Ren Care. 2009 Dec;35 Suppl 2:14-24. doi: 10.1111/j.1755-6686.2009.00125.x. Review.

PMID:
19891681
[PubMed - indexed for MEDLINE]
12.

Hepcidin: clinical utility as a diagnostic tool and therapeutic target.

Coyne DW.

Kidney Int. 2011 Aug;80(3):240-4. doi: 10.1038/ki.2011.141. Epub 2011 Jun 15. Review.

PMID:
21677632
[PubMed - indexed for MEDLINE]
13.

Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?

Malyszko J, Glowinska I, Mysliwiec M.

Transplant Proc. 2012 Dec;44(10):3013-6. doi: 10.1016/j.transproceed.2012.06.070.

PMID:
23195016
[PubMed - indexed for MEDLINE]
14.

Anemia in children with chronic kidney disease.

Koshy SM, Geary DF.

Pediatr Nephrol. 2008 Feb;23(2):209-19. Epub 2007 Jan 24. Review.

PMID:
17245602
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF.

Ann Intern Med. 2010 Jul 6;153(1):23-33. doi: 10.7326/0003-4819-153-1-201007060-00252. Epub 2010 Jun 24. Review.

PMID:
20439566
[PubMed - indexed for MEDLINE]
16.

Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.

Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM.

Ann Pharmacother. 2007 Nov;41(11):1761-9. Epub 2007 Sep 25.

PMID:
17895328
[PubMed - indexed for MEDLINE]
17.

Chronic kidney disease-associated anemia: new remedies.

Del Vecchio L, Cavalli A, Tucci B, Locatelli F.

Curr Opin Investig Drugs. 2010 Sep;11(9):1030-8. Review.

PMID:
20730698
[PubMed - indexed for MEDLINE]
18.

Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management.

Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A.

Blood Purif. 2010;29(1):1-12. doi: 10.1159/000245041. Epub 2009 Oct 8. Review.

PMID:
19816014
[PubMed - indexed for MEDLINE]
Free Article
19.

Anemia management in CKD patients in the era of new US Food and Drug Administration recommendations on the use of erythropoiesis-stimulating agents.

Kaufman JS.

Am J Kidney Dis. 2013 Feb;61(2):191-3. doi: 10.1053/j.ajkd.2012.12.001. No abstract available.

PMID:
23318011
[PubMed - indexed for MEDLINE]
20.

Ferumoxytol for treating iron deficiency anemia in CKD.

Spinowitz BS, Kausz AT, Baptista J, Noble SD, Sothinathan R, Bernardo MV, Brenner L, Pereira BJ.

J Am Soc Nephrol. 2008 Aug;19(8):1599-605. doi: 10.1681/ASN.2007101156. Epub 2008 Jun 4.

PMID:
18525001
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk